- Home
- ALAR vs SGMO Comparison
ALAR vs SGMO Comparison
Compare ALAR & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- SGMO
- Stock Information
- Founded
- ALAR 2013
- SGMO 1995
- Country
- ALAR Israel
- SGMO United States
- Employees
- ALAR N/A
- SGMO N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALAR Technology
- SGMO Health Care
- Exchange
- ALAR Nasdaq
- SGMO Nasdaq
- Market Cap
- ALAR 116.1M
- SGMO 122.8M
- IPO Year
- ALAR 2018
- SGMO 2000
- Fundamental
- Price
- ALAR $16.20
- SGMO $0.55
- Analyst Decision
- ALAR Strong Buy
- SGMO Strong Buy
- Analyst Count
- ALAR 1
- SGMO 7
- Target Price
- ALAR $27.00
- SGMO $5.29
- AVG Volume (30 Days)
- ALAR 123.2K
- SGMO 4.1M
- Earning Date
- ALAR 08-28-2025
- SGMO 11-11-2025
- Dividend Yield
- ALAR N/A
- SGMO N/A
- EPS Growth
- ALAR N/A
- SGMO N/A
- EPS
- ALAR 0.07
- SGMO N/A
- Revenue
- ALAR $30,488,000.00
- SGMO $81,706,000.00
- Revenue This Year
- ALAR $28.77
- SGMO $21.24
- Revenue Next Year
- ALAR $31.83
- SGMO N/A
- P/E Ratio
- ALAR $20.06
- SGMO N/A
- Revenue Growth
- ALAR N/A
- SGMO 565.52
- 52 Week Low
- ALAR $5.45
- SGMO $0.41
- 52 Week High
- ALAR $21.50
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- ALAR 57.23
- SGMO 58.27
- Support Level
- ALAR $15.00
- SGMO $0.49
- Resistance Level
- ALAR $16.59
- SGMO $0.56
- Average True Range (ATR)
- ALAR 0.86
- SGMO 0.04
- MACD
- ALAR -0.01
- SGMO 0.00
- Stochastic Oscillator
- ALAR 85.69
- SGMO 100.00
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.